Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic…

Overview of attention for article published in Systematic Reviews, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 20,184 followers.

RT @mendibe_mar: Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response b…

12 Jul 2022

Reply Repost Favourite

RT @mendibe_mar: Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response b…

12 Jul 2022

Reply Repost Favourite

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol | Systematic Reviews | Full Text https://t.co/

12 Jul 2022

Reply Repost Favourite

RT @BibliotecaHUVH: Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment respons…

12 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.